Judge Shapiro D J 's Rulings on Biosimilar Drug Regulation

Explore Judge Shapiro D J 's 1 rulings on biosimilar drug regulation. AI-powered summaries and legal analysis.

1

Cases

1

Defendant Win

Courts

Judge Shapiro D J 's Biosimilar Drug Regulation Opinions (1)

Johnson & Johnson v. Samsung Bioepis Co Ltd

Third Circuit: Biosimilar Renflexis Does Not Infringe Remicade Patents

Third Circuit · 2026-04-14 · Defendant Win · Impact: 75/100

Johnson & Johnson v. Samsung Bioepis Co Ltd, decided by Third Circuit on April 14, 2026, resulted in a defendant win outcome. The Third Circuit affirmed the District Court's grant of summary judgment ...

Frequently Asked Questions

Q: How many biosimilar drug regulation cases has Judge Shapiro D J decided?

CaseLawBrief tracks 1 biosimilar drug regulation cases decided by Judge Shapiro D J . The count updates as new opinions are published.

Q: What is Judge Shapiro D J 's ruling pattern on biosimilar drug regulation cases?

Based on tracked cases, outcomes include: Defendant Win: 1.

Q: Which courts has Judge Shapiro D J served on for biosimilar drug regulation cases?

Judge Shapiro D J has decided biosimilar drug regulation cases in: ca3.

Explore More

All Judge Shapiro D J Cases All Biosimilar Drug Regulation Cases All Judges All Topics Search